A researcher at The University of Texas at Arlington has found that blood vessels within bone marrow may progressively convert into bone with advancing age.
Higher levels of blood high-density lipoprotein (HDL) -- or good cholesterol -- may improve fatigue in multiple sclerosis patients, according to a new University at Buffalo-led study.
Advances in diabetes care over the past two decades have not effectively improved diabetes outcomes for American adults, in particular young, female and non-white adults with diabetes.
Mistrust of health care providers, fueled by painful experiences with racism, makes African American men more likely to delay routine screenings and doctor's appointments, according to a new study in the journal Behavioral Medicine by the Health Disparities Institute (HDI) at UConn Health, with potentially serious implications for their overall health.
Researchers show that TARA's heart-on-a-chip system replicates drug responses found in adult humans, validating it as an accurate model for cardiac safety during drug development.
The amount of remnant particle cholesterol in the blood, the so-called ugly cholesterol, is much higher than previously believed. This is shown in new research from the University of Copenhagen and Copenhagen University Hospital. The discovery may have implications for future prevention and treatment of cardiovascular disease.
A nationwide study of 120,173 people in France, who were aged 75 between 2012 and 2014 and had been taking statins continuously for two years, has found those who stopped taking their statins had a 33% increased risk of being admitted to hospital with heart or blood vessel problems during an average follow-up period of 2.4 years. The study is published in the European Heart Journal.
A single viral factor released from HIV-infected cells may wreak havoc on the body and lead to the development of metabolic diseases. By explaining the mechanisms, it could pave the way for targeted treatment to help provide a longer and healthier life for the 36 million people globally living with HIV/AIDS.
A multi-institutional team led by research faculty at Children's National in Washington, DC, finds that extracellular vesicles (EVs) derived from kids' fat can play a pivotal role in ratcheting up risk for atherosclerotic cardiovascular disease well before any worrisome symptoms become visible.
Individuals at high risk for cardiovascular events had more heart attacks, strokes and other cardiovascular events when they were unable to obtain their prescribed LDL-cholesterol lowering medication. In a new study in Circulation: Cardiovascular Quality and Outcomes, researchers with the FH Foundation found that individuals with familial hypercholesterolemia (FH) or atherosclerotic heart disease (ASCVD) whose PCSK9 inhibitors (PCSK9is) were rejected by their insurance plan had an immediate 16% increased risk of a cardiovascular event during the 12-month study period.